British American Tobacco stock (GB0002875804): BofA raises estimates amid strong US momentum

Bank of America remains bullish on British American Tobacco, lifting price targets and estimates on robust US performance as of May 14, 2026. The ADR trades at $64.56 on NYSE.

British American Tobacco saw positive analyst attention on May 14, 2026, as Bank of America maintained its bullish stance, citing strong US momentum and raising price objective estimates, according to Marketscreener as of 05/14/2026. The company's shares on the London Stock Exchange rose 2.47% to 4,925.50 GBX intraday, while the NYSE ADR gained 1.45% to $64.56, per MarketBeat as of 05/14/2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: British American Tobacco p.l.c.
• Sector/industry: Tobacco and nicotine products
• Headquarters/country: London, UK
• Core markets: US, Europe, emerging markets
• Key revenue drivers: Cigarettes, modern oral, vaping
• Home exchange/listing venue: London Stock Exchange (BATS), NYSE (BTI)
• Trading currency: GBX (LSE), USD (NYSE)

British American Tobacco: core business model

British American Tobacco p.l.c. operates as a multinational tobacco and nicotine products company, producing cigarettes, vaping products, and modern oral nicotine pouches. The firm maintains a portfolio of leading brands including Lucky Strike, Dunhill, and Vuse, targeting both combustible and reduced-risk products. Headquartered in London, it generates revenue across 180 countries with a focus on transitioning smokers to non-combustible alternatives.

In its latest final earnings reported on February 12, 2026, the company posted an EPS of GBX 176.76 on a trailing EPS of GBX 349.10, according to MarketBeat as of 05/14/2026. This reflects ongoing efforts to balance legacy tobacco sales with growth in newer categories amid regulatory pressures worldwide.

Main revenue and product drivers for British American Tobacco

Combustible tobacco remains the largest revenue contributor, though modern oral products showed 48% growth in H2 2025, per company disclosures. The US market, a key driver for US investors via the NYSE-listed ADR (BTI), benefits from strong demand in these segments. Dividend yield stands at 5.11-5.45%, ranking in the top quartile of payers, as noted by MarketBeat.

On May 13, 2026, the company filed a 6-K with the SEC disclosing managerial transactions, highlighting ongoing insider activity, according to StockTitan as of 05/14/2026. Shares on LSE climbed 3.73% to 4,807.00p on May 13, per StockInvest.us data.

Industry trends and competitive position

The tobacco sector faces regulatory scrutiny and a shift to smoke-free products, where British American Tobacco invests heavily in R&D for vaping and oral nicotine. It competes with Philip Morris International and Altria, holding significant US exposure relevant to American portfolios. BofA's upgrade underscores momentum in the US, a critical market amid declining volumes elsewhere.

Why British American Tobacco matters for US investors

Listed as BTI on NYSE, British American Tobacco offers US investors direct access to a high-yield global tobacco leader with substantial American operations. The ADR's performance tracks US consumer trends in nicotine products, providing diversification from pure domestic plays while delivering attractive dividends tied to the broader economy.

Conclusion

British American Tobacco continues navigating industry challenges with growth in non-combustibles and strong US performance, as highlighted by BofA's positive update on May 14, 2026. Recent price gains and high dividend yield maintain appeal, though regulatory risks persist. Investors track upcoming earnings and product shifts for further insights.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.